The obesogenic and diabetogenic effects of the environmental toxin bisphenol A during critical windows of development are well recognized. Liver and skeletal muscle play a central role in the control of glucose production, utilization, and storage. OBJECTIVES: We hypothesized that maternal bisphenol A exposure disrupts insulin signaling in rat offspring liver and skeletal muscle. We determined the protein expression of hepatic and skeletal muscle insulin signaling molecules including insulin receptor beta, its downstream target insulin receptor substrate 1 and glucose transporters (glucose transporter 2, glucose transporter 4), and hepatic glucose-regulating enzymes phosphoenolpyruvate carboxykinase and glucokinase. STUDY DESIGN: Rat dams had ad libitum access to filtered drinking water (control) or drinking water with bisphenol A from 2 weeks prior to mating and through pregnancy and lactation. Offspring litters were standardized to 4 males and 4 females and nursed by the same dam. At weaning, bisphenol A exposure was removed from all offspring. Glucose tolerance was tested at 6 weeks and 6 months. Liver and skeletal muscle was collected from 3 week old and 10 month old offspring for protein expression (Western blot) of insulin receptor beta, insulin receptor substrate 1, glucose transporter 2, glucose transporter 4, phosphoenolpyruvate carboxykinase, and glucokinase.
T he worldwide incidence of metabolic diseases, including type 2 diabetes, has increased dramatically over the past 30 years. 1, 2 Whereas there is little doubt that diet, exercise, and genetic factors all play a role in an individual's susceptibility to type 2 diabetes, evidence from human and animal models suggests that predisposition to the development of metabolic disease also begins in utero. 3 This concept of developmental programming states that early environmental exposures during pregnancy and/or lactation programs changes in gene expression that alters growth and development with consequences for the long-term health of the offspring. 3 Recent public health concerns have been raised regarding the potential longterm effects of exposure to the endocrine disrupter chemical bisphenol A (4,4-dihydroxyl-2,2-diphenylpropane; BPA) during the vulnerable period of perinatal development. 4 BPA is an industrial chemical used primarily to make polycarbonate plastic and epoxy resins. It is used in the production of everyday items including carbon-free paper, sports equipment, medical devices, reusable food and drink containers, and dental sealants.
The abundant use of BPA has made this endocrine disrupter chemical ubiquitous in our environment, leading to chronic low-dose exposure. 5 According to the 2003e2004 National Health and Nutrition Examination Survey, BPA was detected in the urine of >90% of the survey participants. 6 Moreover, children had the highest urinary BPA concentrations, followed by adolescents and adults. 6 In addition, BPA has been detected in maternal serum, amniotic fluid, fetal cord blood, and breast milk. 7 During periods of increased glucose availability, tight homeostatic regulation of blood glucose levels is primarily achieved by the actions of insulin to inhibit hepatic glucose production and to increase the uptake and storage of glucose in peripheral insulin-sensitive tissues, such as skeletal muscle. 8 Hence, any disruption to glucose-stimulated insulin secretion or to the ability of peripheral tissues to respond to insulin action via intracellular insulin signaling pathways will likely have adverse consequences for glucoregulation. 8 Using National Health and Nutrition Examination Survey data (2003e2004, 2005e2006, 2007e2008) , the majority of published human epidemiological studies have shown positive associations between urinary concentrations of BPA, glucose intolerance, and diabetes.
Similarly, studies in animals have shown impaired glucose tolerance and altered secretion of insulin from the endocrine pancreas in adult mice [13] [14] [15] [16] and rats 17, 18 that were exposed to BPA perinatally. Studies in adult mice and rats have implicated changes in pancreatic beta cell mass as well as lower expression of genes that normally optimize beta cell function, such as Pdx-1, in the mechanism by which BPA alters glucoregulation.
14,17 However, homeostatic regulation of blood glucose is determined by both pancreatic beta cell insulin secretion and its effects on peripheral, insulin-sensitive tissues.
The biological effects of insulin, including the uptake of glucose into fat and muscle cells and the suppression of glucose synthesis in the liver, are mediated by the activation of the insulin receptor and the biochemical insulin transduction pathway. Previous studies have focused on BPA-induced alterations in insulin secretion and beta cell mass or function, 14, 17 but whether perinatal exposure to BPA has age-, sex-, or tissue-specific effects on the protein abundance of insulin signaling components is unknown. Hence, the current study determined whether perinatal exposure to BPA alters the protein abundance of insulin signaling components in offspring liver and muscle at weaning and in adulthood. At birth, blood from all excess newborn pups was pooled to create sufficient volume to determine the plasma BPA level. Newborns from BPAtreated dams had a plasma BPA level (0.62 ng/mL) within the range of values measured in human umbilical cord blood, whereas BPA was undetectable in plasma from the newborns of control dams. 19, 20 There were no differences in body weights between control (male: 6.85 AE 0.10 g; female: 6.62 AE 0.11 g) and BPA-treated (male: 6.84 AE 0.18 g; female: 6.65 AE 0.08 g; 2-way analysis of variance [ANOVA] with sex and treatment as factors) offspring within each sex at birth or at any time point thereafter.
Materials and Methods
At 11 weeks of age, the rats were mated and continued on their respective treatments during pregnancy and lactation. After birth, at 1 day of age, litters were culled to 8 pups (4 males and 4 females) per dam to standardize nursing. All pups were nursed by their respective dams until 3 weeks of age. At weaning BPA exposure was removed and the rat pups were housed 4 per cage with the same sex. The animals were separated to 2 per cage at 125 g and into singular housing when their weight was above 250 g, such that no cage contained more than 500 g of total rat body weight.
All rats were housed in BPA-free polycarbonate cages (Ancar Corp, Bellmore, NY). The cages were filled with paper chip bedding (Sherpherd Specialty Papers, Watertown, TN) with cardboard tubes for enrichment. All weaned offspring had ad libitum access to a standard control diet (LabDiet 5001; LabDiet, St Louis, MO) and filtered drinking water with no further BPA exposure.
Glucose tolerance and plasma analyses
At 6 and 24 weeks of age, 1 male and 1 female offspring from each litter underwent a glucose tolerance test (GTT). Following an overnight fast, Dglucose (1 mg/g body weight) was injected intraperitoneally (i.p.) in conscious rats.
Blood glucose values were determined in tail bleed blood prior to (time 0) and 15, 30, 60, 120, and 180 minutes after glucose administration using a Hemocue B-glucose analyzer (HemoCue Inc, Mission Viejo, CA). Plasma insulin concentrations were determined prior to the glucose challenge (time 0; 6 and 24 weeks of age) and during the challenge at 15 and 180 minutes (24 weeks). Blood was collected into heparinized tubes at 0, 15, and 180 minutes and centrifuged immediately at 3000 Â g and 4 C for 10 minutes, and the plasma was stored at e80 C. Plasma insulin concentrations were measured using a commercially available, rodent-specific enzyme-linked immunosorbent assay kit (10-1250-01; Mercodia, Uppsala, Sweden).
Tissue collection
At 3 weeks and 10 months of age, offspring were anesthetized by 5% isoflurane/2% oxygen by mask and exsanguinated via cardiac puncture. Euthanasia was confirmed by decapitation. Plasma as well as liver and gastrocnemius skeletal muscle tissue was collected, snap frozen in liquid nitrogen, and stored at e80 C until analysis. The offspring in the current study were part of a larger study of the longterm effects of perinatal BPA exposure on offspring growth and appetite regulation (these data will be published separately). Consequently, offspring tissues were not available at the exact ages corresponding to the in vivo measurements of glucose clearance. Tissues collected at ages closest to the in vivo experiments were used to determine the protein abundances of components of the insulin signaling pathway.
Protein extraction and Western blotting
Liver and skeletal muscle protein was extracted in radioimmunoprecipitation assay buffer (1Â) containing protease inhibitors (HALT cocktail; Pierce, Rockford, IL), and the total protein ajog.org OBSTETRICS Original Research concentration in the supernatant was determined using a bicinchoninic acid assay (BCA kit; Pierce).
Western blotting was performed as previously described, 21 using primary antibodies from Santa Cruz Biotechnology (Dallas, TX; 1:1000) against insulin receptor beta subunit (IR-b; sc-711), insulin receptor substrate 1 (IRS-1; sc-559), glucose transporter 2 (GLUT2; sc-9117), glucose transporter 4 (GLUT4; sc-1607), phosphoenolpyruvate carboxykinase (sc-32879), and glucokinase (sc-7908). Goat antirabbit immunoglobin G horseradish peroxidase conjugate (number 1706515; Bio-Rad Laboratories, Hercules, CA; 1:2000) and donkey antigoat immunoglobin G horseradish peroxidase conjugate (sc-2020; Santa Cruz Biotechnology; 1:2000) were used as secondary antibodies. The depicted bands had the expected molecular weights.
Statistical analysis
For all studies 5-6 offspring were studied per group (1 of the 4 male offspring and 1 of the 4 female offspring from each of 6 control and 5 BPA-treated litters), with the exception of newborn plasma for BPA measurement in which the blood was pooled from all excess pups. No differences were found in the protein abundance of insulin signaling components in skeletal muscle from the 6 week old glucose-intolerant male offspring; hence, skeletal muscle was not analyzed from 6 week old female offspring that did not show a glucose intolerant phenotype at 3 weeks of age.
Values are means AE SEM. Statistical significance (version 2.0; SigmaStat Statistical Software, San Jose, CA) was assessed using an unpaired Student t test and a 2-way, repeated-measures ANOVA, as appropriate. Statistical significance was accepted when P < .05.
Results

Fasting glucose and insulin
At 3 and 6 weeks of age, male and female fasting blood glucose and plasma insulin concentrations, and the ratio of insulin to glucose, were not different between control and BPA offspring. In contrast, at 24 weeks of age, male BPA offspring had higher plasma insulin concentrations, although the blood glucose concentrations and the ratio of insulin to glucose were comparable with controls.
In addition, 24 week old female BPA offspring had similar blood glucose concentrations and insulin levels, although the ratio of insulin to glucose was increased compared with controls (Table) .
Glucose tolerance test
At both ages (6 and 24 weeks), administration of glucose generated an immediate increase in the blood concentration of glucose (P < .05) that was maximal between 15 and 30 minutes after the injection in both BPA and control offspring (Figure 1 ). In 6 week old BPA males, the area under the glucose curve was higher than in controls and remained higher in adulthood at 24 weeks of age (Figure 1, A and C) . However, perinatal exposure to BPA did not At 24 weeks of age, the increase in blood glucose was accompanied by rapid insulin release in all offspring. Although there were similar rates of glucose clearance in BPA and control male and female offspring, the area under the glucosestimulated insulin curve was higher in both BPA males and females compared with controls ( Figures 1, C and D) . Additionally, the ratio of stimulated insulin to glucose was higher in both male and female BPA offspring (Table) .
Liver insulin signaling components
At 3 weeks of age, the protein abundance of GLUT2 was lower and the abundances of the 200 kDa IR-b precursor and IRS-1 were higher in male BPA offspring compared with controls ( Figure 2A) . However, perinatal BPA did not affect any of the liver insulin-signaling components in female BPA offspring (Figure 2, C and D) . Furthermore, the protein abundance of glucokinase or phosphoenolpyruvate carboxykinase liver enzymes was not different in either sex (Figure 2, AeD) .
At 10 months of age, there were no differences in the protein abundance of any of the measured liver insulin signaling components or enzymes in BPA male or female offspring (Figure 2, B and D) .
Skeletal muscle insulin signaling components
At 3 weeks of age, the protein abundance of GLUT4 and IR-b was not different between male BPA and control offspring ( Figure 3A) . In contrast, at 10 months of age, the protein abundance of GLUT4 was lower in both BPA male and female offspring. In addition, BPA males had a higher abundance of IR-b compared with controls ( Figure 3 , B and C).
Comment
Perinatal exposure to BPA was associated with age-and sex-dependent changes in glucose tolerance and insulin sensitivity, consistent with previous rodent studies. 14, 17, 22, 23 Because blood glucose regulation is determined by both insulin secretion and peripheral insulin sensitivity, we determined the effects of perinatal BPA on the protein abundance of components of the insulin signaling Original Research OBSTETRICS ajog.org pathways in offspring liver and skeletal muscle. The present study showed lower protein abundance of GLUT2 and higher protein abundance of IRS-1 in the liver of male BPA-treated offspring at weaning. In addition, both BPA male and female offspring had lower protein abundance of GLUT4 in skeletal muscle in adulthood.
Higher abundance of the insulin receptor precursor molecule in male offspring liver at weaning, as well as in skeletal muscle in adulthood, was not associated with age-, sex-, or tissuespecific changes in the protein abundance of the mature, functional IR-b subunit. These data contrast with the decreased abundance of the mature IR-b subunit in liver and skeletal muscle from adult rats after exposure to a high dose (200 mg/kg body weight) of BPA. 24, 25 Conversely, the protein abundance of IRS-1 was higher in the liver of male BPA-treated offspring, consistent with BPA-increased IRS-1 in adult mouse liver. 26 In the latter study, the authors speculated that higher liver protein abundance of IRS-1 in BPA than control mice may counteract the BPA-induced decrease in insulin receptor phosphorylation as a compensatory mechanism to avoid insulin resistance. 26 Whether BPA altered insulin receptor phosphorylation in the current study is unknown because the data are limited by the collection of offspring tissues after an overnight fast and not under insulin-stimulated conditions.
At weaning, the protein abundance of the bidirectional glucose transporter GLUT2 was lower in liver tissue from BPA-treated than from control males. Similarly, lower GLUT2 abundance has been demonstrated in isolated pancreatic islets in vitro, 27 in adult rat testis and pancreas in vivo, 28 and in the pancreas of male and female offspring after BPA treatment. 17 In contrast, studies of adult male mice and rats exposed to BPA demonstrated variable, dose-dependent effects on GLUT2 expression in the liver. 24, 29 Notably, lower liver GLUT2 abundance in the current study did not likely impair the liver maintenance of blood glucose levels in the fasted state because there were no differences in fasting blood glucose levels between the control and BPA males at 3 weeks of age.
A lower abundance of the glucose transporter GLUT4 in skeletal muscle from adult male and female offspring is consistent with previous studies of BPA-treated adult male rats. 25 Because skeletal muscle is the major peripheral site of glucose uptake, usage, and storage, any BPA-induced deficiency in skeletal muscle insulin signaling is likely to predispose offspring to the development of insulin resistance. 30 Moreover, heterozygous GLUT4 knockout mice exhibit peripheral insulin resistance, specifically implicating the GLUT4 transporter in the development of insulin resistance. [31] [32] [33] Accordingly, in the current study, both male and female adult offspring were insulin resistant, as evidenced by higher insulin to glucose ratios and greater area under the insulin curves during the GTT. However, because tissue for the protein studies was not collected at the time of the GTT, further mechanistic studies are required to confirm that lower GLUT4 abundance contributes to BPA-induced glucose intolerance and to determine whether perinatal BPA affects the translocation of the GLUT4 transporter to the plasma membrane and subsequent glucose uptake. 25 Perinatal exposure to BPA induces sex-specific changes in the rat liver lipid metabolism 34 and disrupts sexually dimorphic behaviors in mice. 35 The molecular mechanism underlying the sex-specific effects of BPA in these studies and in the current study is unknown but may be mediated by BPA interactions with estrogen receptors and estrogen-signaling pathways.
BPA can bind to both classical and nonclassical G proteinecoupled estrogen receptors [36] [37] [38] that regulate central and peripheral glucose metabolism 39 and may interfere with estrogen signaling by activation or inhibition of the receptor. 40 Classical estrogen receptors show sex-and tissue-specific patterns of expression throughout development, but whether these signaling pathways are disrupted during perinatal development in the insulin-sensitive tissues of BPA-exposed offspring is unknown.
BPA may also alter insulin signaling by altered methylation of genes, such as GLUT4. 41 Indeed, altered methylation of the estrogen receptor a (Esr1) and several other genes has been shown following perinatal exposure to BPA. 35, 42 Gene methylation and demethylation is catalyzed by DNA methyltransferase (DNMT) enzymes. Accordingly, altered expression of the enzymes DNMT1 and DNMT3a have been demonstrated in rodent brain tissue 35 and in preadipocytes exposed to BPA in vivo and in vitro, respectively. 19 Further studies of receptor expression patterns and site-specific gene methylation are required to correlate epigenetic effects of BPA and sex-and tissuespecific changes in gene expression and offspring phenotypes. In addition, although there were no differences in weights between control and BPA offspring in the current study, changes in the insulin-signaling pathway may have occurred secondary to BPA-induced changes in offspring body composition (fat mass), lipid homeostasis, and/or inflammation. 19, 34 Using a model of maternal treatment with BPA that produces maternal and newborn plasma BPA concentrations that are similar to the range of values measured in serum from pregnant women and human umbilical cord blood, 19 we have shown that BPA disrupts glucose homeostasis and alters the abundance of insulin-signaling components in the exposed offspring. Early-life exposure to BPA should therefore be considered a possible risk factor for the development of insulin resistance and diabetes. n
